1. Home
  2. AIRE vs QNRX Comparison

AIRE vs QNRX Comparison

Compare AIRE & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

HOLD

Current Price

$1.36

Market Cap

11.5M

Sector

N/A

ML Signal

HOLD

Logo Quoin Pharmaceuticals Ltd.

QNRX

Quoin Pharmaceuticals Ltd.

HOLD

Current Price

$7.06

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRE
QNRX
Founded
2021
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
9.2M
IPO Year
2023
2023

Fundamental Metrics

Financial Performance
Metric
AIRE
QNRX
Price
$1.36
$7.06
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$1.30
N/A
AVG Volume (30 Days)
88.1K
901.6K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
60.34
N/A
EPS
N/A
N/A
Revenue
$4,518,498.00
N/A
Revenue This Year
$129.06
N/A
Revenue Next Year
$83.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
376.42
N/A
52 Week Low
$0.16
$3.25
52 Week High
$3.98
$41.80

Technical Indicators

Market Signals
Indicator
AIRE
QNRX
Relative Strength Index (RSI) 41.82 67.72
Support Level $1.29 $7.00
Resistance Level $1.85 $8.25
Average True Range (ATR) 0.11 0.52
MACD -0.02 -0.01
Stochastic Oscillator 26.53 76.21

Price Performance

Historical Comparison
AIRE
QNRX

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are Homebuying Services and the Technology Services segment.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: